| Targeting liposomal chemotherapy via both tumor cell–specific and tumor vasculature–specific ligands potentiates therapeutic efficacy F Pastorino, C Brignole, D Di Paolo, B Nico, A Pezzolo, D Marimpietri, ... Cancer research 66 (20), 10073-10082, 2006 | 290 | 2006 |
| Effect of bortezomib on human neuroblastoma cell growth, apoptosis, and angiogenesis C Brignole, D Marimpietri, F Pastorino, B Nico, D Di Paolo, M Cioni, ... Journal of the National Cancer Institute 98 (16), 1142-1157, 2006 | 157 | 2006 |
| Targeting macrophages as a potential therapeutic intervention: impact on inflammatory diseases and cancer M Ponzoni, F Pastorino, D Di Paolo, P Perri, C Brignole International journal of molecular sciences 19 (7), 1953, 2018 | 153 | 2018 |
| Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin F Pastorino, D Di Paolo, F Piccardi, B Nico, D Ribatti, A Daga, G Baio, ... Clinical Cancer Research 14 (22), 7320-7329, 2008 | 109 | 2008 |
| A novel liposomal Clodronate depletes tumor-associated macrophages in primary and metastatic melanoma: Anti-angiogenic and anti-tumor effects F Piaggio, V Kondylis, F Pastorino, D Di Paolo, P Perri, I Cossu, F Schorn, ... Journal of Controlled Release 223, 165-177, 2016 | 105 | 2016 |
| Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma M Loi, S Marchiò, P Becherini, D Di Paolo, M Soster, F Curnis, C Brignole, ... Journal of controlled release 145 (1), 66-73, 2010 | 91 | 2010 |
| Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis D Marimpietri, C Brignole, B Nico, F Pastorino, A Pezzolo, F Piccardi, ... Clinical Cancer Research 13 (13), 3977-3988, 2007 | 88 | 2007 |
| Therapeutic targeting of TLR9 inhibits cell growth and induces apoptosis in neuroblastoma C Brignole, D Marimpietri, DD Paolo, P Perri, F Morandi, F Pastorino, ... Cancer research 70 (23), 9816-9826, 2010 | 86 | 2010 |
| Neuroblastoma-targeted nanoparticles entrapping siRNA specifically knockdown ALK D Di Paolo, C Brignole, F Pastorino, R Carosio, A Zorzoli, M Rossi, M Loi, ... Molecular Therapy 19 (6), 1131-1140, 2011 | 78 | 2011 |
| Selective therapeutic targeting of the anaplastic lymphoma kinase with liposomal siRNA induces apoptosis and inhibits angiogenesis in neuroblastoma D Di Paolo, C Ambrogio, F Pastorino, C Brignole, C Martinengo, ... Molecular Therapy 19 (12), 2201-2212, 2011 | 76 | 2011 |
| A proof-of-concept for epigenetic therapy of tissue fibrosis: inhibition of liver fibrosis progression by 3-deazaneplanocin A M Zeybel, S Luli, L Sabater, T Hardy, F Oakley, J Leslie, A Page, ... Molecular Therapy 25 (1), 218-231, 2017 | 74 | 2017 |
| PHOX2B-Mediated Regulation of ALK Expression: In Vitro Identification of a Functional Relationship between Two Genes Involved in Neuroblastoma T Bachetti, D Di Paolo, S Di Lascio, V Mirisola, C Brignole, M Bellotti, ... PloS one 5 (10), e13108, 2010 | 70 | 2010 |
| The use of the orthotopic model to validate antivascular therapies for cancer. M Loi, D Di Paolo, P Becherini, A Zorzoli, P Perri, R Carosio, M Cilli, ... International Journal of Developmental Biology 55, 2011 | 61 | 2011 |
| Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma G Zuccari, A Milelli, F Pastorino, M Loi, A Petretto, A Parise, C Marchetti, ... Journal of controlled release 211, 44-52, 2015 | 60 | 2015 |
| Neuroblastoma targeting by c-myb-selective antisense oligonucleotides entrapped in anti-GD2 immunoliposome: immune cell-mediated anti-tumor activities C Brignole, D Marimpietri, G Pagnan, D Di Paolo, M Zancolli, V Pistoia, ... Cancer letters 228 (1-2), 181-186, 2005 | 55 | 2005 |
| Enhanced anti-tumor and anti-angiogenic efficacy of a novel liposomal fenretinide on human neuroblastoma D Di Paolo, F Pastorino, G Zuccari, I Caffa, M Loi, D Marimpietri, ... Journal of controlled release 170 (3), 445-451, 2013 | 52 | 2013 |
| Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings M Loi, D Di Paolo, M Soster, C Brignole, A Bartolini, L Emionite, J Sun, ... Journal of controlled release 170 (2), 233-241, 2013 | 52 | 2013 |
| The combined therapeutic effects of bortezomib and fenretinide on neuroblastoma cells involve endoplasmic reticulum stress response G Pagnan, D Di Paolo, R Carosio, F Pastorino, D Marimpietri, C Brignole, ... Clinical Cancer Research 15 (4), 1199-1209, 2009 | 50 | 2009 |
| Drug delivery systems: application of liposomal anti-tumor agents to neuroectodermal cancer treatment D Di Paolo, F Pastorino, C Brignole, D Marimpietri, M Loi, M Ponzoni, ... Tumori Journal 94 (2), 246-253, 2008 | 41 | 2008 |
| Coated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer models M Moro, D Di Paolo, M Milione, G Centonze, V Bornaghi, C Borzi, ... Journal of controlled release 308, 44-56, 2019 | 39 | 2019 |
Michele CilliOspedale Policlinico San Martino - Genova - ITVerified email at hsanmartino.it
